- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 84-98 of
283 results
2043 Exhibit: Clinical Study ReportACZ ROS 01, A phase II, randomized, partial blin...
Document
IPR2018-00608, No. 2043-82 Exhibit - Clinical Study ReportACZ ROS 01, A phase II, randomized, partial blind, parallel group, active and vehiclecontrolled, multicenter study of the safety and ef...
|
|
Cite Document
2020 Exhibit: European Commissions Scientific Committee on Consumer Safety, O...
Document
IPR2018-00608, No. 2020-58 Exhibit - European Commissions Scientific Committee on Consumer Safety, Opinion on Diethylene Glycol Monoethyl Ether DEGEE 2010 Part 1 of 2 (P.T.A.B. Nov. 2...
|
|
Cite Document
2012 Exhibit: World Health Organization Alert No 117, Antimalarial chlorproguanil d...
Document
IPR2018-00608, No. 2012-49 Exhibit - World Health Organization Alert No 117, Antimalarial chlorproguanil dapsone LapDap¿¿¿ withdrawn following demonstration of post treatment haemolytic an...
|
|
Cite Document
2005 Exhibit: International Patent Application Publication No WO 2011014627 ¿¿¿Ah...
Document
IPR2018-00608, No. 2005-42 Exhibit - International Patent Application Publication No WO 2011014627 ¿¿¿Ahluwalia¿¿¿ (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2016 Exhibit: Kirk A James et al, ¿¿¿Emerging drugs for acne,¿¿¿ Expert Opin Emergi...
Document
IPR2018-00608, No. 2016-54 Exhibit - Kirk A James et al, ¿¿¿Emerging drugs for acne,¿¿¿ Expert Opin Emerging Drugs 144 649¿¿¿659 2009 ¿¿¿James I¿¿¿ (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2036 Exhibit: P Marazzi et al, Clinical evaluation of Double Strength IsotrexinTM ve...
Document
IPR2018-00608, No. 2036-66 Exhibit - P Marazzi et al, Clinical evaluation of Double Strength IsotrexinTM versus Benzamycin¿¿ in the topical treatment of mild to moderate acne vulgaris, 13 Journ...
|
|
Cite Document
2050 Exhibit: NDA 21 794 FDA approval letter July 7, 2005
Document
IPR2018-00608, No. 2050-90 Exhibit - NDA 21 794 FDA approval letter July 7, 2005 (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2038 Exhibit: Frank C Powell, Rosacea, 352 New Eng J Med 793¿¿¿803 2005
Document
IPR2018-00608, No. 2038-68 Exhibit - Frank C Powell, Rosacea, 352 New Eng J Med 793¿¿¿803 2005 (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2031 Exhibit: Physicians¿¿¿ Desk Reference 2765¿¿¿2767 2012 excerpt
Document
IPR2018-00608, No. 2031-76 Exhibit - Physicians¿¿¿ Desk Reference 2765¿¿¿2767 2012 excerpt (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2028 Exhibit: William D James, Acne, 352 New Eng J Medicine 1463¿¿¿1472 2005 ¿¿¿...
Document
IPR2018-00608, No. 2028-73 Exhibit - William D James, Acne, 352 New Eng J Medicine 1463¿¿¿1472 2005 ¿¿¿James II¿¿¿ (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2026 Exhibit: Stephen Titus Joshua Hodge, Diagnosis and Treatment of Acne, 86 A...
Document
IPR2018-00608, No. 2026-71 Exhibit - Stephen Titus Joshua Hodge, Diagnosis and Treatment of Acne, 86 Am Family Physician 734¿¿¿740 2012 ¿¿¿Titus¿¿¿ (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2004 Exhibit: Curriculum Vitae for Professor Alexander M Klibanov
Document
IPR2018-00608, No. 2004-41 Exhibit - Curriculum Vitae for Professor Alexander M Klibanov (P.T.A.B. Nov. 29, 2018)
|
|
Cite Document
2041 Exhibit: Michael Ghods et al, The Role of Dapsone Gel in the Acne Armament...
Document
IPR2018-00608, No. 2041-80 Exhibit - Michael Ghods et al, The Role of Dapsone Gel in the Acne Armamentarium, The Dermatologist June 10, 2010, available at httpswwwthe dermatologistcomc...
|
|
Cite Document
2032 Exhibit: Gabriella Fabbrocini et al, Resveratrol Containing Gel for the Treatme...
Document
IPR2018-00608, No. 2032-77 Exhibit - Gabriella Fabbrocini et al, Resveratrol Containing Gel for the Treatment of Acne Vulgaris, 12 Am J of Clinical Dermatology 131¿¿¿141 2011 ¿¿¿Fabbrocini¿¿¿ (P...
|
|
Cite Document
2043 Exhibit: Clinical Study Report¿¿¿ACZ ROS 01, A phase II, randomized, partial b...
Document
IPR2018-00608, No. 2043-82 Exhibit - Clinical Study Report¿¿¿ACZ ROS 01, A phase II, randomized, partial blind, parallel group, active and vehiclecontrolled, multicenter study of the safety and ...
|
|
Cite Document
